Skip to content

As we begin rolling out injectable cabotegravir (CAB) as PrEP, what lessons have we learned from the first 10 years of oral PrEP implementation? How can we do better with a new PrEP intervention that offers new opportunities and distinct challenges?

Expert speakers – including global public health leaders, clinical providers, advocates, and CAB consumers – will discuss the moving parts and priorities involved in delivering injectable cabotegravir for PrEP quickly, efficiently, strategically, and equitably.

Please join us for a dynamic, engaging, and participatory conversation.

Our speakers include:

  • Rachel Baggaley, World Health Organization
  • Caroline Carnevale, New York Presbyterian Hospital
  • Monica Gandhi, University of California San Francisco
  • Mitchell Warren, AVAC

Visit the Choice Agenda’s webpage.